Search Orphan Drug Designations and Approvals
-
Generic Name: | (R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride |
---|---|
Date Designated: | 11/19/2015 |
Orphan Designation: | Treatment of cholangiocarcinoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Basilea Pharmaceutical International Ltd. Grenzacherstrasse 487 P.O. Box Basel Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-